Direct display of hematopoietic tyrosine kinase receptor expression profiles in KG1 cells by PCR using degenerate primers

Leukemia

Volumn 10, Issue 8, 1996, Pages 1395-1399

  Visser, M ^a   Sonneveld, R D ^a   Willemze, R ^a   Landegent, J E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Expression profiles; Hematopoietic tyrosine kinase receptors; KG1; RET

Indexed keywords

COMPLEMENTARY DNA; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PRIMER DNA; PROTEIN TYROSINE KINASE; RECEPTOR;

ARTICLE; DNA FINGERPRINTING; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; MYELOBLAST; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE C KIT; ONCOGENE RET; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMYELOCYTE; PROTO ONCOGENE; RECEPTOR GENE; RESTRICTION FRAGMENT;

EID: 0029780734     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Rosnet O, Stephenson D, Mattei M-G, Marchetto S, Shibuya M, Chapman VM, Birnbaum D. Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 1993; 8: 173-179.
2. Yarden Y, Escobedo JA, Kuang W-J, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U, Fried VA, Ullrich A, Williams LT. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 1986; 323: 226-232.
3. Claesson-Welsh L, Eriksson A, Moren A, Severinsson L, Ek B, Ostman A, Betsholtz C, Heldin C-H. cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 1988; 8: 3476-3486.
4. Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM, Ullrich A. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 1986; 320: 277-280.
5. Yarden Y, Kuang W-J, Yang-Feng TL, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987; 6: 3341-3351.
6. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991; 65: 1143-1152.
7. Rosnet O, Marchetto S, deLapeyriere O, Birnbaum D. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene 1991; 6: 1641-1650.
8. - syndrome. Cell 1985; 42: 421-428.
9. Nocka K, Majumder S, Chabot B, Ray P, Cervone M, Bernstein A, Besmer P. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - evidence for an impaired c-kit kinase in mutant mice. Genes Dev 1989; 3: 816-826.
10. André C, d'Auriol L, Lacombe C, Gisselbrecht S, Galibert F. C-kit mRNA expression in human and murine hematopoietic cell lines. Oncogene 1989; 4: 1047-1049.
11. Rosnet O, Schiff C, Pebusque M-J, Marchetto S, Tonnelle C, Toiron Y, Birg F, Birnbaum D. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993; 82: 1110-1119.
12. Soriano P. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev 1994; 8: 1888-1896.
13. Wilks AF. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 1603-1607.
14. Partanen J, Mäkelä TP, Alitalo R, Lehväslaiho H, Alitalo K. Putative tyrosine kinases expressed in K-562 human leukemia cells. Proc Natl Acad Sci USA 1990; 87: 891 3-8917.
15. Gibson S, Leung B, Squire JA, Hill M, Arima N, Goss P, Hogg D, Mills GB. Identification, cloning and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q. Blood 1993; 82: 1561-1572.
16. Koeffler HP, Golde DW. Acute myelogenous leukemia: A human cell line responsive to colony-stimulating activity. Science 1987; 200: 1153-1154.
17. Broudy VC, Lin N, Zsebo KM, Birkett NC, Smith KA, Bernstein ID, Papayannopoulou T. Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood 1992; 79: 338-346.
18. Meierhoff G, Dehmel U, Gruss H-J, Rosnet O, Birnbaum D, Quentmeier H, Dirks W, Drexler HG. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 1995; 9: 1368-1372.
19. Chomczynski P, Sacchi N. Single step method for RNA isolation by guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
20. Kaashoek JGJ, Mout R, Falkenburg JHF, Willemze R, Fibbe WE, Landegent JE. Cytokine production of the bladder carcinoma cell line 5637: a rapid analysis of mRNA expression levels using a cDNA-PCR procedure. Lymph Cyt Res 1991; 10: 231-235.
21. Sambrook I, Fritsch EF, Maniatis R. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratories: Cold Spring Harbor, NY, 1989.
22. Takahashi M, Cooper GM. Ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 1987; 4: 1378-1385.
23. Takahashi M, Ritz J, Cooper CM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985; 42: 581-588.
24. Grieco M, Santoro M, Berlingieri MT, Mellilo RM, Pierotti MA, Della Porta G, Fusco A, Vecchio G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thryoid papillary carcinomas. Cell 1990; 60: 557-563.
25. Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti MA. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit Rlα of cyclic AMP-dependent protein kinase A. Mol Cell Biol 1993; 13: 358-366.
26. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A. Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 1994; 9: 509-516.
27. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ. Germ-line mutations of the RET protooncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460.
28. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JBJ, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, Neumann HPH, Thibodeau SN, Ponder BAJ. Specific mutations of the RET protooncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 1994; 6: 70-74.
29. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA Jr, Goodfellow PJ, Donis-Keller H. Single missense mutations in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasis type 2B. Proc Natl Acad Sci USA 1994; 91: 1579-1583.
30. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kääriäinen H, Martucciello G. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 1994; 367: 377-378.
31. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fékété C, Ponder BAJ, Munnich A. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 1994; 367: 378-380.